DexCom, Inc. logo
DexCom, Inc. (DXCM)
Compare

DexCom, Inc. (DXCM) Price/FCF Ratio: 20.82

popular:market cap|pe ratio|revenue|price history|total return

Is DexCom, Inc.’s Price/FCF ratio high or low?

DexCom, Inc.'s Price/FCF ratio of 20.82 is 88% below its 5-year average of 176.73, near the low end of its 5-year range (15.92–967.38).

The Price/FCF ratio for DexCom, Inc. (DXCM) is 20.82. It is below its 12-month average by 42.34% (36.11).

P/E Ratio|FCF Growth|Operating Margin|All Metrics

DXCM Price/FCF Ratio Chart

DXCM Price/FCF Ratio
20.82-65.35% 1Y
Zoom

DXCM Average Price/FCF Ratio Chart

DXCM Current vs Average Price/FCF Ratio Chart

DXCM Price/FCF Ratio Metrics

PRICE/FCF RATIO

20.82

PRICE/FCF RATIO AVG TTM

36.11

PRICE/FCF RATIO AVG 3Y

64.02

PRICE/FCF RATIO AVG 5Y

176.73

PRICE/FCF RATIO AVG 10Y

519.28

PRICE/FCF RATIO AVG 15Y

522.24

PRICE/FCF RATIO AVG 20Y

522.24

CURRENT VS TTM AVG

-42.34%

CURRENT VS 3Y AVG

-67.48%

CURRENT VS 5Y AVG

-88.22%

CURRENT VS 10Y AVG

-95.99%

CURRENT VS 15Y AVG

-96.01%

CURRENT VS 20Y AVG

-96.01%

DXCM Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
DexCom, Inc. (DXCM)$29.24B20.8236.1164.02176.73
Biogen Inc. (BIIB)$29.00B11.1211.0718.7318.56
IQVIA Holdings Inc. (IQV)$30.60B11.6513.9720.3721.30
Medline Inc. (MDLN)$30.90B19.7721.1521.1521.15
Veeva Systems Inc. (VEEV)$26.73B52.4330.6233.9839.46
Centene Corporation (CNC)$31.94B5.058.6622.8417.16
Zoetis Inc. (ZTS)$34.20B16.1325.5439.2845.60
Waters Corporation (WAT)$23.83B113.8340.1239.3938.40
Mettler-Toledo International Inc. (MTD)$22.85B28.9231.2531.1136.01
BioNTech SE (BNTX)$21.81B14.5836.2810.8414.33

Free Cash Flow Valuation

P/FCF Ratio

20.8

FCF Yield

4.80%

DexCom, Inc. Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

DexCom, Inc. Price/FCF Ratio FAQ

What is the Price/FCF ratio for DexCom, Inc. (DXCM)?
The Price/FCF ratio for DXCM stock is 20.82.
Is DexCom, Inc.'s Price/FCF ratio high or low?
DexCom, Inc.'s Price/FCF ratio of 20.82 is 88% below its 5-year average of 176.73, near the low end of its 5-year range (15.92–967.38).
What is the TTM average Price/FCF ratio for DexCom, Inc. (DXCM)?
The TTM average Price/FCF ratio for DXCM stock is 36.11.
What is the 3Y average Price/FCF ratio for DexCom, Inc. (DXCM)?
The 3Y average Price/FCF ratio for DXCM stock is 64.02.
What is the 5Y average Price/FCF ratio for DexCom, Inc. (DXCM)?
The 5Y average Price/FCF ratio for DXCM stock is 176.73.
What is the 10Y average Price/FCF ratio for DexCom, Inc. (DXCM)?
The 10Y average Price/FCF ratio for DXCM stock is 519.28.
What is the 15Y average Price/FCF ratio for DexCom, Inc. (DXCM)?
The 15Y average Price/FCF ratio for DXCM stock is 522.24.
What is the 20Y average Price/FCF ratio for DexCom, Inc. (DXCM)?
The 20Y average Price/FCF ratio for DXCM stock is 522.24.

DexCom, Inc. Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-1020.82
2026-06-0921.53
2026-06-0821.10
2026-06-0520.06
2026-06-0419.99
2026-06-0320.04
2026-06-0220.23
2026-06-0120.62
2026-05-2920.31
2026-05-2819.92
2026-05-2719.35
2026-05-2619.83
2026-05-2219.85
2026-05-2119.80
2026-05-2019.67
2026-05-1918.44
2026-05-1817.92
2026-05-1516.97
2026-05-1415.92
2026-05-1316.13
2026-05-1216.84
2026-05-1116.34
2026-05-0816.69
2026-05-0716.77
2026-05-0616.62
2026-05-0516.38
2026-05-0416.53
2026-05-0116.89
2026-04-3016.40
2026-04-2921.32
2026-04-2821.97
2026-04-2722.74
2026-04-2422.80
2026-04-2323.22
2026-04-2223.48
2026-04-2123.18
2026-04-2023.93
2026-04-1723.69
2026-04-1622.67
2026-04-1522.79
2026-04-1423.31
2026-04-1323.37
2026-04-1023.71
2026-04-0924.32
2026-04-0824.37
2026-04-0723.37
2026-04-0623.41
2026-04-0223.04
2026-04-0123.10
2026-03-3123.26
2026-03-3022.92
2026-03-2723.05
2026-03-2624.47
2026-03-2524.75
2026-03-2424.66
2026-03-2324.42
2026-03-2024.79
2026-03-1924.91
2026-03-1825.06
2026-03-1724.93
2026-03-1624.57
2026-03-1323.79
2026-03-1224.17
2026-03-1124.56
2026-03-1025.10
2026-03-0925.46
2026-03-0625.22
2026-03-0526.18
2026-03-0427.00
2026-03-0327.06
2026-03-0227.32
2026-02-2727.19
2026-02-2627.54
2026-02-2527.09
2026-02-2427.07
2026-02-2327.13
2026-02-2027.06
2026-02-1926.76
2026-02-1826.96
2026-02-1726.08
2026-02-1325.93
2026-02-1224.10
2026-02-1126.15
2026-02-1026.15
2026-02-0926.92
2026-02-0626.84
2026-02-0526.81
2026-02-0427.17
2026-02-0327.48
2026-02-0227.83
2026-01-3028.02
2026-01-2928.39
2026-01-2828.14
2026-01-2728.26
2026-01-2628.14
2026-01-2327.95
2026-01-2228.36
2026-01-2127.67
2026-01-2027.14
2026-01-1626.68
2026-01-1526.56
2026-01-1426.74
2026-01-1326.95
2026-01-1227.23
2026-01-0925.86
2026-01-0826.25
2026-01-0726.89
2026-01-0626.81
2026-01-0525.95
2026-01-0225.53
2025-12-3125.46
2025-12-3025.73
2025-12-2925.88
2025-12-2625.92
2025-12-2425.87
2025-12-2325.65
2025-12-2225.87
2025-12-1925.34
2025-12-1825.29
2025-12-1725.23
2025-12-1625.46
2025-12-1525.22
2025-12-1225.69
2025-12-1126.45
2025-12-1025.92
2025-12-0925.45
2025-12-0825.18
2025-12-0525.13
2025-12-0425.03
2025-12-0324.88
2025-12-0224.73
2025-12-0124.37
2025-11-2824.35
2025-11-2623.99
2025-11-2523.67
2025-11-2423.87
2025-11-2123.11
2025-11-2022.41
2025-11-1922.92
2025-11-1823.08
2025-11-1722.44
2025-11-1422.27
2025-11-1322.91
2025-11-1222.87
2025-11-1122.30
2025-11-1021.04
2025-11-0721.10
2025-11-0622.26
2025-11-0522.74
2025-11-0423.47
2025-11-0323.18
2025-10-3122.34
2025-10-3026.17
2025-10-2948.76
2025-10-2849.51
2025-10-2750.51
2025-10-2450.30
2025-10-2350.82
2025-10-2250.56
2025-10-2149.88
2025-10-2048.94
2025-10-1747.63
2025-10-1647.44
2025-10-1546.78
2025-10-1447.35
2025-10-1346.63
2025-10-1046.57
2025-10-0948.69
2025-10-0848.47
2025-10-0747.22
2025-10-0647.46
2025-10-0347.95
2025-10-0247.51
2025-10-0147.26
2025-09-3048.12
2025-09-2947.53
2025-09-2647.99
2025-09-2548.84
2025-09-2448.27
2025-09-2348.77
2025-09-2249.71
2025-09-1948.24
2025-09-1854.19
2025-09-1754.67
2025-09-1654.74
2025-09-1554.05
2025-09-1254.51
2025-09-1154.35
2025-09-1054.35
2025-09-0956.07
2025-09-0855.78
2025-09-0557.58
2025-09-0457.75
2025-09-0356.44
2025-09-0253.13
2025-08-2953.88
2025-08-2853.69
2025-08-2754.62
2025-08-2654.44
2025-08-2554.32
2025-08-2258.83
2025-08-2157.65
2025-08-2058.41
2025-08-1957.85
2025-08-1857.80
2025-08-1557.89
2025-08-1457.18
2025-08-1357.18
2025-08-1257.33
2025-08-1155.67
2025-08-0856.40
2025-08-0754.64
2025-08-0654.64
2025-08-0553.96
2025-08-0454.53
2025-08-0156.70
2025-07-3157.76
2025-07-3063.69
2025-07-2963.30
2025-07-2863.43
2025-07-2563.04
2025-07-2461.45
2025-07-2361.23
2025-07-2260.30
2025-07-2159.53
2025-07-1859.43
2025-07-1759.58
2025-07-1659.60
2025-07-1560.06
2025-07-1460.45
2025-07-1159.06
2025-07-1060.54
2025-07-0960.13
2025-07-0859.34
2025-07-0758.76
2025-07-0358.75
2025-07-0259.21
2025-07-0159.21
2025-06-3061.84
2025-06-2761.16
2025-06-2660.25
2025-06-2559.99
2025-06-2462.04
2025-06-2356.56
2025-06-2056.68
2025-06-1857.39
2025-06-1757.97
2025-06-1658.80
2025-06-1358.09
2025-06-1258.70
2025-06-1158.79
2025-06-1060.09
2025-06-0960.70
2025-06-0661.40
2025-06-0560.74
2025-06-0460.65
2025-06-0361.49
2025-06-0260.58
2025-05-3060.78
2025-05-2960.12

Showing the most recent 260 of 2,707 data points. The chart above shows the full history.

Related Metrics

P/E RatioFCF GrowthOperating MarginAll Metrics

About DexCom, Inc.

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

San Diego, CA
10,200 employees
www.dexcom.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Jacob Steven Leach
View full financials